FluoGuide A/S, a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today announced positive results from the first part of its ongoing FG001-CT-005 Phase 2 trial ...

Century Therapeutics (IPSC) downgraded to Hold after CNTY-101 halted and slow clinical progress. Click here to read my most ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

Dr. John Spencer Ellis has launched Rep Radar, a free platform from Reputation Return that delivers comprehensive ...

Mosquitoes in Clark County have tested positive for West Nile virus for the first time this season, officials with the Southern Nevada Health District announced Wednesday.

Primary CNS lymphoma is a rare cancer that arises from malignant white blood cells. Affected individuals develop tumors in ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

COPENHAGEN, DK / ACCESS Newswire / June 29, 2026 / FluoGuide A/S ("FluoGuide" or the "Company") (STO:FLUO), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today anno ...

France has recorded its first Ebola case linked to the ongoing Congo outbreak, after a doctor who returned from a humanitarian mission tested positive.

A positive case of Ebola virus has been identified in France in a patient traveling back from Congo, the French Ministry of Health said W ...

This segment focuses on the clinical implications of the SERENA-6 trial and its evaluation of circulating tumor DNA–guided treatment switching in hormone receptor–positive, HER2-negative metastatic ...

( (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive results from the FB102 double-blind placebo-controlled ...